04:41 PM EDT, 07/02/2025 (MT Newswires) -- Inovio Pharmaceuticals ( INO ) said late Wednesday it plans a proposed public offering of common shares and accompanying series A and B warrants to purchase common shares.

The company will offer underwriters a 30-day option to buy additional common shares and warrants up to 15% of the offering size, according to a statement.

Inovio currently intends to use the offering net proceeds primarily for the development of its clinical pipeline and for general corporate purposes, a regulatory filing shows.

Shares were down 22.8% during after-hours trading.